Selected research
Market Structure
Global Powder Absorbable Hemostat Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Powder Absorbable Hemostat market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Powder Absorbable Hemostat is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Powder Absorbable Hemostat is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Powder Absorbable Hemostat is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Powder Absorbable Hemostat is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Powder Absorbable Hemostat include Johnson & Johnson, Pfizer, Baxter, Medira, MBP, Hemostasis, Gelita Medical, Ferrosan Medical Devices and Equimedical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Powder Absorbable Hemostat market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Powder Absorbable Hemostat and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Powder Absorbable Hemostat sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Powder Absorbable Hemostat market size, projected growth trends, production technologies, key applications, and end-use industries.
Powder Absorbable Hemostat Segment by Company
Johnson & Johnson
Pfizer
Baxter
Medira
MBP
Hemostasis
Gelita Medical
Ferrosan Medical Devices
Equimedical
CSL Behring
Celox
C. R. Bard
Biocer
Powder Absorbable Hemostat Segment by Type
Gelatin
Fibrin
Cellulose
Others
Powder Absorbable Hemostat Segment by Application
Hospitals
Clinics
Others
Powder Absorbable Hemostat Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Powder Absorbable Hemostat market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Powder Absorbable Hemostat and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Powder Absorbable Hemostat.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Powder Absorbable Hemostat market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Powder Absorbable Hemostat manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Powder Absorbable Hemostat in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Powder Absorbable Hemostat in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Gelatin
- Fibrin
- Cellulose
- Others
Applications
- Hospitals
- Clinics
- Others
Companies covered
- Johnson & Johnson
- Pfizer
- Baxter
- Medira
- MBP
- Hemostasis
- Gelita Medical
- Ferrosan Medical Devices
- Equimedical
- CSL Behring
- Celox
- C. R. Bard
- Biocer
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Powder Absorbable Hemostat Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Powder Absorbable Hemostat Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Powder Absorbable Hemostat Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Powder Absorbable Hemostat Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Powder Absorbable Hemostat Market Dynamics
- 2.1 Powder Absorbable Hemostat Industry Trends
- 2.2 Powder Absorbable Hemostat Industry Drivers
- 2.3 Powder Absorbable Hemostat Industry Opportunities and Challenges
- 2.4 Powder Absorbable Hemostat Industry Restraints
3 Powder Absorbable Hemostat Market by Manufacturers
- 3.1 Global Powder Absorbable Hemostat Revenue by Manufacturers (2021-2026)
- 3.2 Global Powder Absorbable Hemostat Sales by Manufacturers (2021-2026)
- 3.3 Global Powder Absorbable Hemostat Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Powder Absorbable Hemostat Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Powder Absorbable Hemostat Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Powder Absorbable Hemostat Manufacturers, Product Type & Application
- 3.7 Global Powder Absorbable Hemostat Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Powder Absorbable Hemostat Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Powder Absorbable Hemostat Players Market Share by Revenue in 2025
- 3.8.3 2025 Powder Absorbable Hemostat Tier 1, Tier 2, and Tier 3
4 Powder Absorbable Hemostat Market by Type
- 4.1 Powder Absorbable Hemostat Type Introduction
- 4.1.1 Gelatin
- 4.1.2 Fibrin
- 4.1.3 Cellulose
- 4.1.4 Others
- 4.2 Global Powder Absorbable Hemostat Sales by Type
- 4.2.1 Global Powder Absorbable Hemostat Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Powder Absorbable Hemostat Sales by Type (2021-2032)
- 4.2.3 Global Powder Absorbable Hemostat Sales Market Share by Type (2021-2032)
- 4.3 Global Powder Absorbable Hemostat Revenue by Type
- 4.3.1 Global Powder Absorbable Hemostat Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Powder Absorbable Hemostat Revenue by Type (2021-2032)
- 4.3.3 Global Powder Absorbable Hemostat Revenue Market Share by Type (2021-2032)
5 Powder Absorbable Hemostat Market by Application
- 5.1 Powder Absorbable Hemostat Application Introduction
- 5.1.1 Hospitals
- 5.1.2 Clinics
- 5.1.3 Others
- 5.2 Global Powder Absorbable Hemostat Sales by Application
- 5.2.1 Global Powder Absorbable Hemostat Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Powder Absorbable Hemostat Sales by Application (2021-2032)
- 5.2.3 Global Powder Absorbable Hemostat Sales Market Share by Application (2021-2032)
- 5.3 Global Powder Absorbable Hemostat Revenue by Application
- 5.3.1 Global Powder Absorbable Hemostat Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Powder Absorbable Hemostat Revenue by Application (2021-2032)
- 5.3.3 Global Powder Absorbable Hemostat Revenue Market Share by Application (2021-2032)
6 Global Powder Absorbable Hemostat Sales by Region
- 6.1 Global Powder Absorbable Hemostat Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Powder Absorbable Hemostat Sales by Region (2021-2032)
- 6.2.1 Global Powder Absorbable Hemostat Sales by Region (2021-2026)
- 6.2.2 Global Powder Absorbable Hemostat Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Powder Absorbable Hemostat Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Powder Absorbable Hemostat Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Powder Absorbable Hemostat Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Powder Absorbable Hemostat Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Powder Absorbable Hemostat Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Powder Absorbable Hemostat Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Powder Absorbable Hemostat Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Powder Absorbable Hemostat Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Powder Absorbable Hemostat Revenue by Region
- 7.1 Global Powder Absorbable Hemostat Revenue by Region
- 7.1.1 Global Powder Absorbable Hemostat Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Powder Absorbable Hemostat Revenue by Region (2021-2026)
- 7.1.3 Global Powder Absorbable Hemostat Revenue by Region (2027-2032)
- 7.1.4 Global Powder Absorbable Hemostat Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Powder Absorbable Hemostat Revenue (2021-2032)
- 7.2.2 North America Powder Absorbable Hemostat Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Powder Absorbable Hemostat Revenue (2021-2032)
- 7.3.2 Europe Powder Absorbable Hemostat Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Powder Absorbable Hemostat Revenue (2021-2032)
- 7.4.2 Asia-Pacific Powder Absorbable Hemostat Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Powder Absorbable Hemostat Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Powder Absorbable Hemostat Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Johnson & Johnson
- 8.1.1 Johnson & Johnson Company Information
- 8.1.2 Johnson & Johnson Business Overview
- 8.1.3 Johnson & Johnson Powder Absorbable Hemostat Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Johnson & Johnson Powder Absorbable Hemostat Product Portfolio
- 8.1.5 Johnson & Johnson Recent Developments
- 8.2 Pfizer
- 8.2.1 Pfizer Company Information
- 8.2.2 Pfizer Business Overview
- 8.2.3 Pfizer Powder Absorbable Hemostat Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Pfizer Powder Absorbable Hemostat Product Portfolio
- 8.2.5 Pfizer Recent Developments
- 8.3 Baxter
- 8.3.1 Baxter Company Information
- 8.3.2 Baxter Business Overview
- 8.3.3 Baxter Powder Absorbable Hemostat Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Baxter Powder Absorbable Hemostat Product Portfolio
- 8.3.5 Baxter Recent Developments
- 8.4 Medira
- 8.4.1 Medira Company Information
- 8.4.2 Medira Business Overview
- 8.4.3 Medira Powder Absorbable Hemostat Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Medira Powder Absorbable Hemostat Product Portfolio
- 8.4.5 Medira Recent Developments
- 8.5 MBP
- 8.5.1 MBP Company Information
- 8.5.2 MBP Business Overview
- 8.5.3 MBP Powder Absorbable Hemostat Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 MBP Powder Absorbable Hemostat Product Portfolio
- 8.5.5 MBP Recent Developments
- 8.6 Hemostasis
- 8.6.1 Hemostasis Company Information
- 8.6.2 Hemostasis Business Overview
- 8.6.3 Hemostasis Powder Absorbable Hemostat Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Hemostasis Powder Absorbable Hemostat Product Portfolio
- 8.6.5 Hemostasis Recent Developments
- 8.7 Gelita Medical
- 8.7.1 Gelita Medical Company Information
- 8.7.2 Gelita Medical Business Overview
- 8.7.3 Gelita Medical Powder Absorbable Hemostat Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Gelita Medical Powder Absorbable Hemostat Product Portfolio
- 8.7.5 Gelita Medical Recent Developments
- 8.8 Ferrosan Medical Devices
- 8.8.1 Ferrosan Medical Devices Company Information
- 8.8.2 Ferrosan Medical Devices Business Overview
- 8.8.3 Ferrosan Medical Devices Powder Absorbable Hemostat Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Ferrosan Medical Devices Powder Absorbable Hemostat Product Portfolio
- 8.8.5 Ferrosan Medical Devices Recent Developments
- 8.9 Equimedical
- 8.9.1 Equimedical Company Information
- 8.9.2 Equimedical Business Overview
- 8.9.3 Equimedical Powder Absorbable Hemostat Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Equimedical Powder Absorbable Hemostat Product Portfolio
- 8.9.5 Equimedical Recent Developments
- 8.10 CSL Behring
- 8.10.1 CSL Behring Company Information
- 8.10.2 CSL Behring Business Overview
- 8.10.3 CSL Behring Powder Absorbable Hemostat Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 CSL Behring Powder Absorbable Hemostat Product Portfolio
- 8.10.5 CSL Behring Recent Developments
- 8.11 Celox
- 8.11.1 Celox Company Information
- 8.11.2 Celox Business Overview
- 8.11.3 Celox Powder Absorbable Hemostat Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Celox Powder Absorbable Hemostat Product Portfolio
- 8.11.5 Celox Recent Developments
- 8.12 C. R. Bard
- 8.12.1 C. R. Bard Company Information
- 8.12.2 C. R. Bard Business Overview
- 8.12.3 C. R. Bard Powder Absorbable Hemostat Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 C. R. Bard Powder Absorbable Hemostat Product Portfolio
- 8.12.5 C. R. Bard Recent Developments
- 8.13 Biocer
- 8.13.1 Biocer Company Information
- 8.13.2 Biocer Business Overview
- 8.13.3 Biocer Powder Absorbable Hemostat Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Biocer Powder Absorbable Hemostat Product Portfolio
- 8.13.5 Biocer Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Powder Absorbable Hemostat Value Chain Analysis
- 9.1.1 Powder Absorbable Hemostat Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Powder Absorbable Hemostat Production Mode & Process
- 9.2 Powder Absorbable Hemostat Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Powder Absorbable Hemostat Distributors
- 9.2.3 Powder Absorbable Hemostat Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst